Genomic Interplay between Neoneurogenesis and Neoangiogenesis in Carcinogenesis: Therapeutic Interventions
Cancers · 16.03.2023 · 15 (6) · 1805
DOI: 10.3390/cancers15061805 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cancers, online erschienen am 16.03.2023. Verfasst von Zodwa Dlamini und 5 weiteren Autor:innen. Beteiligte Einrichtung: SAMRC Precision Oncology Research Unit (PORU), DSI/NRF SARChI Chair in Precision Oncology and Cancer Prevention (POCP), Pan African Cancer Research I…. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 140 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: South African Medical Research Council (SAMRC), National Research Foundation (NRF).
Abstract (Originalsprache)
Angiogenesis, the generation of new blood vessels, is one of the hallmarks of cancer. The growing tumor requires nutrients and oxygen. Recent evidence has shown that tumors release signals to attract new nerve fibers and stimulate the growth of new nerve fibers. Neurogenesis, neural extension, and axonogenesis assist in the migration of cancer cells. Cancer cells can use both blood vessels and nerve fibers as routes for cells to move along. In this way, neurogenesis and angiogenesis both contribute to cancer metastasis. As a result, tumor-induced neurogenesis joins angiogenesis and immunosuppression as aberrant processes that are exacerbated within the tumor microenvironment. The relationship between these processes contributes to cancer development and progression. The interplay between these systems is brought about by cytokines, neurotransmitters, and neuromodulators, which activate signaling pathways that are common to angiogenesis and the nervous tissue. These include the AKT signaling pathways, the MAPK pathway, and the Ras signaling pathway. These processes also both require the remodeling of tissues. The interplay of these processes in cancer provides the opportunity to develop novel therapies that can be used to target these processes.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- SAMRC Precision Oncology Research Unit (PORU), DSI/NRF SARChI Chair in Precision Oncology and Cancer Prevention (POCP), Pan African Cancer Research Institute (PACRI), University of Pretoria, Pretoria 0028, South Africa.
- Department of Medical Oncology, Faculty of Health Sciences, Steve Biko Academic Hospital, University of Pretoria, Pretoria 0028, South Africa.
- Department of Surgery, Steve Biko Academic Hospital, University of Pretoria, Pretoria 0028, South Africa.
- Centre for Cancer Sciences, Division of Cancer and Stem Cells, Biodiscovery Institute, University of Nottingham, Nottingham NG7 2RD, UK.
ORCID-Profile: Zodwa Dlamini, Thulo Molefi, Botle Precious Damane, David Owen Bates
Förderung
- South African Medical Research Council (SAMRC)
- National Research Foundation (NRF)
Zitieren
APA
Dlamini, Z., Khanyile, R., Molefi, T., Damane, B. P., Bates, D. O., & Hull, R. (2023). Genomic Interplay between Neoneurogenesis and Neoangiogenesis in Carcinogenesis: Therapeutic Interventions. Cancers, 15(6), 1805. https://doi.org/10.3390/cancers15061805
Vancouver
Dlamini Z, Khanyile R, Molefi T, Damane BP, Bates DO, Hull R. Genomic Interplay between Neoneurogenesis and Neoangiogenesis in Carcinogenesis: Therapeutic Interventions. Cancers. 2023;15(6):1805. doi:10.3390/cancers15061805
BibTeX
@article{Dlamini2023,
author = {Dlamini, Zodwa and Khanyile, Richard and Molefi, Thulo and Damane, Botle Precious and Bates, David Owen and Hull, Rodney},
title = {Genomic Interplay between Neoneurogenesis and Neoangiogenesis in Carcinogenesis: Therapeutic Interventions},
journal = {Cancers},
year = {2023},
volume = {15},
number = {6},
pages = {1805},
doi = {10.3390/cancers15061805}
}
EUVIMED